[1]
Muhammad Osama, “CRISPR-Cas9 in Precision Oncology: Unraveling Resistance Mechanisms and Redefining Molecular Targeted Cancer Therapy”, J Can Biomol Therap, vol. 3, no. 2, pp. 1–12, Apr. 2026.